Skip to main content
OpenTrials
Completed

NCT Number: NCT00924300

Study to Test the Usefulness of Magnetoencephalography (MEG) Imaging of Cognition in Children and Adolescents

The primary objective of this protocol is to test the feasibility and utility of obtaining magnetoencephalography (MEG) recordings in healthy children and also in children who have a psychiatric or developmental disorder. Secondary objectives are to examine and compare typical and atypical motor, sensory, and cognitive functioning as recorded by MEG, and to identify subpopulation groups for which MEG may be optimal in order to establish feasibility of future hypothesis-driven MEG research.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

4 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States

About this study

Healthy children and those who have a psychiatric or developmental disorder will undergo MEG recording to evaluate whether such children are candidate MEG subjects. Essentially, this feasibility study will examine whether children can remain still enough, complete simple tasks, and produce neurophysiologically consistent responses that would warrant full size studies.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • May or may not have a psychiatric or developmental disorder diagnosis.
  • Outpatient at study entry.
  • Age 4-18 (inclusive).
  • Male or female.
  • Have ability to sit still for 5 minutes or longer.
  • Have ability to comply with basic instructions.
  • Provide written informed assent if willing and able, per local IRB requirements before any study specific procedures are performed.
  • Parent or legal guardian provide written informed consent before any study specific procedures are performed.

Exclusion criteria

  • Ferrous metal permanently attached on or implanted in their body.
  • Metal braces on teeth (i.e. Invisalign braces and cavity fillings are permitted).
  • Has major medical condition, including cancer or hepatitis.
  • Has confounding multiple psychiatric and/or developmental diagnoses, as judged by the principal or co-investigator.
  • Known history or diagnosis of alcohol or substance abuse/dependence.
  • Unable or unwilling to comply with the protocol.
  • Anyone deemed as not appropriate for study participation, as deemed by the principal investigator.

Treatment and study plan

Primary outcomes

  1. Magnetoencephalography (MEG) activation

    Time frame: 2-4 hour single visit

    Task assignment is not randomized, but will be selected based upon age, developmental level of abilities, and disorder of interest, resulting in subjects and subgroups completing different tasks chosen by the principal investigator. Tasks include: auditory stimulation, visual stimulation, somatosensory stimulation, motor tasks, and baseline brain function. While the assigned tasks are performed, the MEG will silently record neuromagnetic responses on a 306-channel whole head Vector View system.

Sponsors and collaborators

Lead sponsor

University of Nebraska

Other

Registry information

Official study title

Magnetoencephalography (MEG) and Magnetic Resonance Imaging (MRI) Studies of Typical and Atypical Cognitive Processes in Children and Adolescents

Important dates

Study start
2009
Primary completion
2017
Study completion
2017
First posted
Jun 18, 2009
Registry last updated
Sep 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.